NOVAST LABS FDA Approval ANDA 204853

ANDA 204853

NOVAST LABS

FDA Drug Application

Application #204853

Application Sponsors

ANDA 204853NOVAST LABS

Marketing Status

Prescription001

Application Products

001CAPSULE, EXTENDED RELEASE;ORAL75MG0INDOMETHACININDOMETHACIN

FDA Submissions

UNKNOWN; ORIG1AP2017-05-08STANDARD
LABELING; LabelingSUPPL2AP2021-04-28STANDARD

Submissions Property Types

ORIG1Null7
SUPPL2Null15

TE Codes

001PrescriptionAB

CDER Filings

NOVAST LABS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 204853
            [companyName] => NOVAST LABS
            [docInserts] => ["",""]
            [products] => [{"drugName":"INDOMETHACIN","activeIngredients":"INDOMETHACIN","strength":"75MG","dosageForm":"CAPSULE, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"05\/08\/2017","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2017-05-08
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.